share_log

藥師幫:(I)有關涉及根據一般授權發行對價股份的目標公司收購事項的須予披露交易;及(II)全球發售所得款項淨額用途變更

YSB: (I) DISCLOSEABLE TRANSACTION IN RELATION TO THE ACQUISITION OF THE TARGET COMPANY INVOLVING ISSUEOF CONSIDERATION SHARES UNDER GENERAL MANDATE; AND (II) CHANGE IN USE OF NET PROCEEDS FROM THE GLOBAL OFFERING

HKEX ·  Oct 15 21:00

Summary by Futu AI

藥師幫(YSB)於2024年10月15日宣佈,將以約人民幣1,034.85億元收購目標公司100%股份,使其成為全資附屬公司。此次收購將通過現金及發行對價股份完成,並預計對價股份將佔擴大後公司已發行股本約8.04%。收購完成後,目標集團的財務業績、資產及負債將納入YSB綜合財務報表。此外,YSB將全球發售所得款項淨額167.4百萬港元的用途更改為投資或收購與公司主要業務相關的項目。收購事項已獲豁免股東批准,但完成仍需待若干先決條件達成。股東及潛在投資者應審慎行事。
藥師幫(YSB)於2024年10月15日宣佈,將以約人民幣1,034.85億元收購目標公司100%股份,使其成為全資附屬公司。此次收購將通過現金及發行對價股份完成,並預計對價股份將佔擴大後公司已發行股本約8.04%。收購完成後,目標集團的財務業績、資產及負債將納入YSB綜合財務報表。此外,YSB將全球發售所得款項淨額167.4百萬港元的用途更改為投資或收購與公司主要業務相關的項目。收購事項已獲豁免股東批准,但完成仍需待若干先決條件達成。股東及潛在投資者應審慎行事。
YSB announced on October 15, 2024, that it will acquire 100% of the target company's shares for approximately RMB 103.485 billion, making it a wholly-owned subsidiary. The acquisition will be completed through cash and issuance of consideration shares, with the consideration shares expected to account for approximately 8.04% of the enlarged company's issued share capital. After the acquisition, the financial performance, assets, and liabilities of the target group will be included in YSB's consolidated financial statements. In addition, YSB will change the purpose of the net proceeds from the global sale of HKD 167.4 million to investment or acquisition of projects related to the company's main business. The acquisition has been exempted shareholder approval, but completion is subject to the satisfaction of certain conditions precedent. Shareholders and potential investors should proceed with caution.
YSB announced on October 15, 2024, that it will acquire 100% of the target company's shares for approximately RMB 103.485 billion, making it a wholly-owned subsidiary. The acquisition will be completed through cash and issuance of consideration shares, with the consideration shares expected to account for approximately 8.04% of the enlarged company's issued share capital. After the acquisition, the financial performance, assets, and liabilities of the target group will be included in YSB's consolidated financial statements. In addition, YSB will change the purpose of the net proceeds from the global sale of HKD 167.4 million to investment or acquisition of projects related to the company's main business. The acquisition has been exempted shareholder approval, but completion is subject to the satisfaction of certain conditions precedent. Shareholders and potential investors should proceed with caution.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.